Abstract
Autism Spectrum Disorder (ASD) is a range of neurodevelopmental conditions characterized by impaired social interaction, learning, and restricted or repetitive behaviors. The underlying causes of ASD are still debated, but researchers have found many physiological traits like gut problems and impaired immune system, to help understand the etiology of ASD. Cerebrospinal fluid (CSF) plays a critical role in maintaining the homeostasis of the neuronal environment and has, therefore, been analyzed in multiple conditions impacting the central nervous system. The study of CSF is crucial to understanding neurological disorders as its composition changes with the disorders, and these changes may indicate various disorder-related physiological mechanisms. For this systematic review, we searched the PubMed database for studies published between 1977 and 2023 and selected 45 studies after manual screening. We took stock of the evidence supporting the hypothesis that ASD alters the properties and composition of CSF. We systematically report on the different attributes of CSF in the ASD population that could be potential biomarkers and assist in understanding the origins and progression of ASD.
We found that in CSF, immune markers, proteins, extra-axial CSF, folate, oxytocin, and vasopressin showed changes in ASD compared to the neurotypicals. We observed many gaps in the literature due to variations in the age and sample size, bias in sex-based reporting of results, and a handful of studies on ASD adults. Our review highlights the need for more research on CSF in autism spectrum disorder to improve understanding of the disorder and identify CSF biomarkers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by a pilot grant from the Carolina Autism & Neurodevelopment (CAN) Research Center (PI: Christian O Reilly) at the University of South Carolina.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email: Vandana Srivastava, vandana{at}email.sc.edu, Christian O’Reilly, christian.oreilly{at}sc.edu
Figure 1: PRISMA diagram updated. Figure 2: deleted. Abstract: updated to add the results and conclusion. Method section: updated to exclude animal studies and case reports. Discussion section is updated. Conclusion section is added.
Data Availability
All data produced in the present work are contained in the manuscript.
